Skip Navigation
Department of Health and Human Services www.hhs.gov
 
 

Previous Stakeholder Group Biosketches

The role of the Stakeholder Group is to support the work of the Effective Health Care Program. The Stakeholder Group is critical to the success of this project, providing input to the program in collaboration with the Effective Health Care Scientific Resource Center (currently based at the Oregon Evidence-based Practice Center).

The role of the Stakeholder Group is to:

  • Provide input on critical research information gaps for practice and policy and on identifying and developing the key research questions to address these gaps.
  • Provide input on implementation issues for Effective Health Care Program reports and findings.
  • Define information needs and identify types of products that will be most useful.
  • Provide feedback from report users.
  • Provide guidance on the program as a whole for quality improvement.
  • Provide guidance on how the program can have more of an impact with users. 

The following members served on the Stakeholder Group for a 2-year term ending in 2010:

Wade M. Aubry, M.D.

Jennifer L. Bright, M.P.A.

W. Gary Erwin, Pharm.D.

Patricia M. Hart, M.D., F.A.C.P.

Maria Carolina Hinestrosa, M.A., M.P.H.*

Peter Juhn, M.D., M.P.H.

Richard A. Justman, M.D.

Sharon Levine, M.D.

David B. Lorber, M.D.

Doris H. Lotz, M.D., M.P.H.

George Lundberg, M.D.

Newell McElwee, Pharm.D., M.S.P.H.

John W. Molina, M.D., J.D.

G. Gregory Raab, Ph.D.

Alan B. Rosenberg, M.D.

Eric M. Wall, M.D., M.P.H.

Anthony C. Wisniewski, Esq.

 

 

Wade M. Aubry, M.D.

Senior Clinical and Policy Advisor, Center for Medical Technology Policy


Dr. Aubry is the senior clinical and policy advisor to the Center for Medical Technology Policy and the senior medical advisor to the California Technology Assessment Forum. These nonprofit organizations use products developed by the Effective Health Care Program to evaluate new technologies and generate new evidence for decision-makers.

Dr. Aubry has an extensive background in technology assessment and coverage decision-making. He is a former senior vice president and chief medical officer of Blue Shield of California and a former chairman of the Medical Advisory Panel of the Blue Cross Blue Shield Association's Technology Evaluation Center. He also has held the position of Medicare Part B Medical Director for Northern California and has served two terms on the Medicare Evidence Development and Coverage Advisory Panel of the Centers for Medicare & Medicaid Services. Dr. Aubry has served on numerous Federal and professional advisory committees related to medical technology, clinical research, and evidence-based medicine for the Institute of Medicine, the National Institutes of Heath, the National Committee for Quality Assurance, the American College of Radiology Imaging Network, and others. He also has experience in health care consulting as a former vice president of the Lewin Group.

Dr. Aubry received his B.S. degree from Stanford University and his M.D. degree from the David Geffen School of Medicine at the University of California, Los Angeles. Trained as an internist and endocrinologist at Cedars-Sinai Medical Center in Los Angeles, he practices medicine at Saint Francis Memorial Hospital in San Francisco, where he is chairman of the Institutional Review Board and a former chief of staff. He also is an associate clinical professor of medicine and a member of the core faculty at the Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco, where he works on medical effectiveness reviews for the California Health Benefits Review Program and teaches clinical medicine and health policy. He is a coauthor of the book False Hope: Bone Marrow Transplantation for Breast Cancer, which details the rise and fall of a controversial procedure that continues to have an impact on policies related to the dissemination of new medical technologies.

Return to Contents
 

 

Jennifer L. Bright, M.P.A.

Executive Director, Society for Healthcare Epidemiology of America
Founder, National Working Group on Evidence-Based Healthcare

 

Ms. Bright is the executive director of the Society for Healthcare Epidemiology of America, a professional society of clinical experts in the prevention and control of health care-associated infections. Previously, as vice president of Mental Health America, she oversaw policy initiatives affecting patients/consumers and families. This work included extensive review of comparative effectiveness research conducted for the Drug Effectiveness Review Project at the Oregon Health & Science University and for the Effective Health Care Program of the Agency for Healthcare Research and Quality.

Ms. Bright has experience in State government relations and consulting, with both Stateside Associates and Booz Allen Hamilton, and throughout her career has focused on a variety of health-policy issues. In 2006, she founded the National Working Group on Evidence-Based Healthcare to represent patient organizations, caregivers, and consumers who are committed to educating stakeholders, facilitating dialogue and engagement in evidence-based health-care initiatives, and promoting the involvement of patients/consumers and caregivers in the development of evidence-based health care.

Ms. Bright earned a B.A. degree in political science from Trinity College and an M.P.A. degree from The George Washington University in Washington, D.C. 

Return to Contents
 

 

W. Gary Erwin, Pharm.D.

Senior Vice President, Professional Services, Omnicare, Inc.
President, Omnicare Senior Health Outcomes

 

Dr. Erwin is the senior vice president of professional services for Omnicare, Inc., a Fortune 500 company based in Covington, Kentucky, and president of Omnicare Senior Health Outcomes. As the leading provider of pharmaceutical care for the elderly, Omnicare serves more than 1 million residents in long-term care facilities and other chronic care settings in the United States and Canada and provides professional pharmacy services to skilled nursing, assisted living, and other institution-based health care providers.

Dr. Erwin oversees the development, management, and measurement of clinical programs for Omnicare Senior Pharmacy Services. Currently, the provided services include the distribution of specialty pharmaceuticals, pharmacist consultations, pharmacy data management, and customer care. Dr. Erwin is also involved in the business development of clinical initiatives, specifically for retiree populations, and oversees the performance of outcomes studies and database reporting. At present, Omnicare offers clinical research services to pharmaceutical and biotechnological companies in 30 countries worldwide.

Before joining Omnicare, Dr. Erwin was a professor of clinical pharmacy at the Philadelphia College of Pharmacy and Science, where he also served as vice president for professional programs. In addition, he served on the faculty at the University of Georgia in Athens, where he specialized in geriatric pharmacotherapy and long-term care.

Dr. Erwin received his B.S. degree in pharmacy from Auburn University in Alabama and his Pharm.D. degree from the University of Kentucky in Lexington. He also completed residency training in hospital pharmacy at the University of Kentucky Medical Center.

Return to Contents
 

 

Patricia M. Hart, M.D., F.A.C.P.

Private Practice, Brooklyn, New York

 

Dr. Hart is a private-practice physician who is board certified in both internal medicine and nephrology. A fellow of the American College of Physicians, she is recognized for her expertise in innovative health strategies and policies that specifically target minorities.

In addition to her clinical practice, Dr. Hart is an advocate for improved health care and has worked tirelessly within organized medicine. She has been appointed and elected to several local and national positions in the National Medical Association, including membership on the Board of Trustees. She has also served on committees of the American College of Physicians and is a member of the Association of Black Cardiologists and of the Association of Minority Nephrologists. Dr. Hart is also involved with and supports several nonprofit foundations and organizations.

Dr. Hart received her B.A. degree in biology from Fordham University in New York City and her M.D. degree from the State University of New York at Buffalo. She completed her internship, residency training, and a fellowship in nephrology at the Harlem Hospital Center in New York City. 

Return to Contents
 

 

Maria Carolina Hinestrosa, M.A., M.P.H.*

Executive Vice President for Programs and Planning at the National Breast Cancer Coalition, and Cofounder of Nueva Vida

 

Carolina Hinestrosa is the Executive Vice President for Programs and Planning at the National Breast Cancer Coalition, and co-founder of Nueva Vida, a support network for Latinas with cancer in the Washington metropolitan area. A two-time breast cancer survivor, Ms. Hinestrosa is a member and former Chair of the Integration Panel of the Department of Defense Breast Cancer Research Program. She has served on various national committees at the National Cancer Institute, the Institute of Medicine, National Quality Forum, the Ethical Force of the American Medical Association, among others. She is a sought-after speaker on breast cancer advocacy in research, access and quality care. Born in Bogotá, Colombia, Ms. Hinestrosa came to the United States in 1985 as a Fulbright scholar. She holds graduate degrees in economics and public health. She has broad experience in strategic planning and nonprofit management in Colombia, New Zealand and the United States.
 

*Ms Hinestrosa passed away in June 2009. She was a valued member of the EHC Stakeholder Group and a tireless promoter for consumer involvement and evidence-based care. We extend our wishes to her family, many friends, and the patients and survivors who were touched by her advocacy, her passion and her wisdom. 

Return to Contents
 

 

Peter Juhn, M.D., M.P.H.

President, Medco Therapeutic Resource Centers, Medco Health Solutions, Inc.

 

Dr. Juhn is the president of Medco Therapeutic Resource Centers, a division of Medco Health Solutions, the largest pharmacy benefits manager in the United States. He is responsible for driving the improvement of clinical outcomes for Medco’s 65 million members through evidence-based education, counseling, and outreach by specialty-trained pharmacists to patients with chronic diseases and to their providers. The Medco resource centers are staffed with more than 1,100 specialist pharmacists, who provide disease-specific therapeutic guidance, safety review, and care coordination for patients who have multiple diseases and who are often treated by multiple physicians who may have prescribed multiple therapies. The centers serve as the clinical platform to improve the health of Medco’s members.

Most recently, Dr. Juhn served as the vice president of evidence and regulatory policy at Johnson & Johnson, where he was responsible for evidence-based medicine at the corporate level. Previously, he served as the vice president of health improvement resources at WellPoint Health Networks, where he managed the disease-management programs for all the operating units. In addition, Dr. Juhn has held senior positions at Kaiser Permanente, including founding executive director of the Care Management Institute, which is Kaiser's corporate disease-management and clinical-policy entity. He also was the president and chief executive officer of CareTouch, Inc., an e-health start-up venture.

Dr. Juhn received a B.A. degree in biology from The University of Chicago in Illinois, an M.D. degree from Harvard Medical School, and an M.P.H. degree from the University of Washington in Seattle, where he was a Robert Wood Johnson Clinical Scholar. He completed a residency in internal medicine at the University of Pennsylvania in Philadelphia. 

Return to Contents
 

 

 

Richard A. Justman, M.D.

National Medical Director, United Healthcare

 

Dr. Justman is the national medical director of United Healthcare, a national health services delivery company. He oversees medical technology assessment, clinical support of pharmacy programs, and clinical support of benefit administration for United Healthcare’s Health Services Division.

Dr. Justman has participated in a number of national initiatives, including the Institute of Medicine Forum on Drug Discovery, Development, and Translation, the American Medical Association CPT-5 Project, and the American Medical Association Initiative to Transform Medical Education. He also has served on the Institute of Medicine Committee to Identify Highly Effective Clinical Services and on an Agency for Healthcare Research and Quality expert panel that prepared the evidence-based report Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families. Dr. Justman gives presentations frequently on the use of clinical evidence to determine the safety and effectiveness of new and emerging medical treatments.

Dr. Justman received his B.A. degree from Cornell University in New York and his M.D. degree from the State University of New York at Buffalo. Board certified in pediatrics, he received his postgraduate training at The University of Chicago Hospitals and Clinics and at the Johns Hopkins Hospital in Baltimore, Maryland. Following his training, he practiced pediatric medicine in Minneapolis, Minnesota, for 15 years before joining United Healthcare.

Return to Contents
 

 

Sharon Levine, M.D.

Associate Executive Director, The Permanente Medical Group, Inc.

 

Dr. Levine is a nationally respected expert and frequent speaker on issues of health policy, drug-use management, and the design and delivery of health care services. As associate executive director for The Permanente Medical Group of Northern California, she oversees clinical education, residency programs, management training, and leadership development for the group's 6,600 physicians, who provide comprehensive health care services to 3.3 million Kaiser Permanente members in Northern California. In her capacity as associate executive director, Dr. Levine is also responsible for government and community relations, health policy and external affairs, and pharmacy policy and drug-use management.

A board-certified pediatrician, Dr. Levine has practiced with The Permanente Medical Group since 1977. During that time, she has held multiple leadership positions within the group, including Chief of Pediatrics, Chief of Quality, and Physician in Charge of the Fremont Medical Center. Dr. Levine began her medical career at the Montgomery-Georgetown Pediatric Comprehensive Care Clinic and the Georgetown University Community Health Plan. In addition, she has held academic appointments at Tufts University School of Medicine and at Georgetown University School of Medicine. She spent 2 years as a clinical associate at the National Institute of Child Health and Human Development, conducting research on infant nutrition.

Dr. Levine is a member of the American College of Physician Executives and of the California Medical Association. She serves on the boards of directors of the Integrated Healthcare Association, the California Association of Physician Groups, the California Hospital Association, the Public Health Institute of California, the Reagan Udall Foundation, and the Women's Foundation of California. She is also a member of the editorial board of Health Affairs. Recently, she was appointed to the Medical Board of California.

Dr. Levine received a B.A. degree from Radcliffe College at Harvard University in Cambridge, Massachusetts, and an M.D. degree from Tufts University School of Medicine in Boston.

Return to Contents
 

 

David B. Lorber, M.D.

Vice President of Medical Affairs, CVS Caremark

 

Dr. Lorber is the vice president of medical affairs for CVS Caremark, a leading pharmaceutical services company that provides, through its affiliates, comprehensive drug benefit services to more than 2,000 health plan sponsors and their plan participants throughout the United States. Dr. Lorber is responsible for the clinical oversight of Caremark programs, focusing on clinical product development and eBusiness initiatives. In addition, he provides clinical support to account management teams and for Medicare Part D initiatives. Dr. Lorber is a fellow of the American College of Chest Physicians and a member of the American College of Emergency Physicians. He has previously served on both the Pulmonology Expert Committee and the Therapeutic Decision Making Expert Committee of United States Pharmacopeia.

Before joining Caremark, Dr. Lorber was the medical director at Blue Cross Blue Shield of New Mexico in Albuquerque. His responsibilities included utilization management, disease management and provider profiling, and oversight of the Pharmacy and Therapeutics Committee. He was responsible for credentialing and served as the company liaison to the New Mexico Medical Society and the New Mexico Department of Health. He also served as the medical director for the Indian Health Service Contract Health Services, a national entity managed by Blue Cross Blue Shield of New Mexico.

Dr. Lorber was a private practitioner in pulmonary, critical care, and internal medicine before he joined Blue Cross Blue Shield of New Mexico. He has held numerous positions in community leadership and professional organizations, serving as president of the New Mexico Chapter of the American Thoracic Society. He has held faculty appointments as an assistant clinical professor of medicine at the University of New Mexico School of Medicine, as an assistant professor at the University of Arizona Medical Center in Tucson, and at the Tucson Veterans Affairs Hospital.

Dr. Lorber received a B.A. degree with distinction in biology from the University of Virginia and earned an M.D. degree from the Medical College of Virginia in Richmond. He completed an internship and a residency in internal medicine at the Medical College of Virginia Hospitals. He is board certified in internal medicine, with specialization in pulmonary disease. 

Return to Contents
 

 

Doris H. Lotz, M.D., M.P.H.

Medicaid Medical Director for the State of New Hampshire

 

Dr. Lotz is the Medicaid medical director for the State of New Hampshire and the program director for the New Hampshire Medicaid Medical Home Project, pharmacy services, and disease management programs. As medical director, she provides clinical guidance for policy and program development and strategic planning. As program director, she provides plenary and implementation leadership to the State’s clinical programs and provides oversight to the State’s $70 million provider payments and $80 million pharmacy program. Under Dr. Lotz’ leadership, the State of New Hampshire was the first Medicaid program to place mental health drugs on its preferred drug list.

Dr. Lotz also is the lead contact for Medicaid quality initiatives for New Hampshire. She is currently the Chair of the Medicaid Medical Directors Learning Network, an Agency for Healthcare Research and Quality (AHRQ) initiative, and was the State’s lead contact for the AHRQ quality-based purchasing learning collaborative. As a part of the quality-based purchasing initiative, Dr. Lotz has developed a Medicaid Report Card for the State and a provider incentive program.

Previously, Dr. Lotz was responsible for the development, procurement, and contracting and implementation of the New Hampshire Medicaid Pharmacy Benefits Management Program, the Outpatient Diagnostic Imaging Prior Authorization initiative, Enhanced Care Coordination, and Independent Review Organization program. She provided clinical leadership to the State's selective contracting initiative in the development of a network of preferred Medicaid providers. In addition, she has worked as a clinician in both private practice and in managed care settings in southern and northern California and in Atlanta, Georgia; as the associate medical director for CIGNA Health Care of New Hampshire; and as the New England Quality Medical Director for CIGNA Health Care.

Dr. Lotz completed her M.D. degree at The Ohio State University College of Medicine in Columbus and an internship and residency in emergency medicine at the Harbor-UCLA Medical Center in Torrance, California. She received her M.P.H. degree from the Johns Hopkins Bloomberg School of Public Health and is currently engaged in a preventive medicine residency at The Johns Hopkins University School of Medicine.

Return to Contents
 

 

George Lundberg, M.D.

Consulting Professor, Stanford University School of Medicine
Distinguished Consultant, Physicians Advocates, Berkeley, CA

 

A pioneer of the medical Internet, Dr. Lundberg is the founding editor-in-chief of both Medscape General Medicine and CBS HealthWatch.com. He is a member of the Institute of Medicine of the National Academy of Sciences and currently is a consulting professor of health policy at the Stanford University School of Medicine in California.

Dr. Lundberg is the past editor-in-chief of scientific information and multimedia for the American Medical Association. In this position, he had editorial responsibility for the Association’s 39 medical journals, American Medical News and various other Internet products, and the Journal of the American Medical Association. Dr. Lundberg has also served as editor-in-chief of Medscape, MedGenMed (later named The Medscape Journal of Medicine), and eMedicine. In 2000, The Industry Standard dubbed Dr. Lundberg "Online Health Care's Medicine Man."

Dr. Lundberg served in the U.S. Army for 11 years during the Vietnam War in San Francisco and in El Paso, Texas. After completing his service with a final rank of lieutenant colonel, Dr. Lundberg entered academic medicine, holding appointments as Professor of Pathology and Associate Director of Laboratories at the Los Angeles County/USC Medical Center, as Professor and Chair of Pathology at the University of California, Davis, and most recently as Adjunct Professor at Harvard University’s School of Public Health. Dr. Lundberg’s major professional interests are toxicology, violence, communication, physician behavior, strategic management, and health system reform. He also has practiced tropical medicine in Central America and forensic medicine in New York State, Sweden, and England. He is a past president of the American Society of Clinical Pathologists.

Dr. Lundberg earned an A.A. degree in premed from North Park College in Chicago, Illinois; a B.S. degree from the University of Alabama at Tuscaloosa; and an M.D. degree from the University of Alabama at Birmingham. He completed his internship at Tripler General Hospital in Honolulu, Hawaii, and his pathology residency at Brooke General Hospital in San Antonio, Texas. He received an M.S. degree in pathology from Baylor College of Medicine in Houston, Texas. Dr. Lundberg has received honorary degrees in science from the State University of New York at Syracuse, Thomas Jefferson University in Philadelphia, the University of Alabama at Birmingham, and the Medical College of Ohio in Toledo.

Return to Contents
 

 

Newell McElwee, Pharm.D., M.S.P.H.

Executive Director, U.S. Outcomes Research, Merck & Co., Inc.

 

Dr. McElwee is the executive director of U.S. Outcomes Research at Merck & Co., where he leads a group of scientists working in the areas of health technology assessment, quality of medical care, and health policy research. He joined the pharmaceutical industry in 1992 and has worked primarily in outcomes research. Before joining Merck & Co. in April 2009, he was vice-president of the Evidence-Based Strategies Group at Pfizer, Inc.

Dr. McElwee has an adjunct faculty appointment at Tufts Medical Center in Boston and has previously held faculty appointments at Rush Medical College in Chicago, the University of Utah in Salt Lake City, and Mercer University in Atlanta.

Dr. McElwee’s business and academic experience has allowed him to investigate the entire span of the evidence continuum. He has identified and prioritized research topics, has generated evidence to answer specific research questions, and has applied and translated evidence into clinical practice. His focus now is to improve the effectiveness and efficiency of our health care system by promoting shared responsibility among all stakeholders and decision-makers and by understanding the unique needs of public and private payers, clinicians, patients, researchers, policy decision-makers, and developers of new technologies so that they can collectively address the challenges facing our health care system.

Dr. McElwee received a B.S. degree in pharmacy from the University of Louisiana at Monroe; a Pharm.D. degree from Mercer University in Atlanta, Georgia; and an M.S.P.H. degree in epidemiology at The University of Utah in Salt Lake City. Dr. McElwee also completed a residency in clinical pharmacy at Fort Worth Osteopathic Hospital, Fort Worth, Texas, and a research fellowship in clinical pharmacology and toxicology at the University of Utah.

Return to Contents
 

 

John W. Molina, M.D., J.D.

Medical Director, Arizona Health Care Cost Containment System

 

Dr. Molina has a dual appointment as the Medical Director and as the Assistant Director for the Division of Fee-For-Service for the Arizona Health Care Cost Containment System (AHCCCS), the State of Arizona’s Medicaid program. As the Medical Director, Dr. Molina provides oversight and direction for the medical and clinical programs utilized by the AHCCCS’s fee-for-service population and for the Arizona Long Term Care Program, contracted Medicaid health plans, and sister State agencies. He also facilitates the engagement of stakeholders and reviews medical policies, new and current coding requirements, and coverage for new technologies.

As the Assistant Director of the AHCCCS Division of Fee-For-Service, Dr. Molina provides managerial leadership for the clinical, administrative, and claims functions for a fee-for-service population of approximately 160,000 members, including Native Americans enrolled in the AHCCCS Fee-For-Service Program and the Federal Emergency Services population of the State of Arizona. As a health plan, the Division pays fee-for-service claims, gives prior authorization for medically necessary services, and conducts collaborative outreach programs with the Indian Health Service (IHS) through its rural and urban clinical programs. The Division is currently working with the IHS to develop new clinical and telemedicine technologies designed to improve chronic care management, increase health care quality, and reduce the cost of health care to Native Americans in remote rural areas and on reservations.

An obstetrician-gynecologist, Dr. Molina has worked as a clinician at the IHS’s Phoenix Indian Medical Center and as a volunteer physician at Las Fuentes Health Clinic of Guadalupe, which he founded in Guadalupe, Arizona, after his residency training. As a nonprofit health care facility, Las Fuentes Health Clinic has provided health care to more than 40,000 uninsured individuals, has sponsored community disease-prevention and health-promotion activities, and has served as a training site for nursing and medical students. Dr. Molina’s academic interests are currently focused on Indian health care law and policy and cultural competency in medicine, and he has published numerous articles on the integration of culture and medicine. Dr. Molina has served as a member of the Advisory Committee on Women’s Health and Research for the National Institutes of Health. He has received numerous leadership awards, including an honorary L.H.D. degree from the A.T. Still University of Health Sciences in Kirksville, Missouri, for his humanitarian work.

Dr. Molina received his M.D. degree from The University of Arizona College of Medicine in Tucson and completed his residency training in obstetrics and gynecology at Texas Tech University Health Science Center in Lubbock. Dr. Molina completed his J.D. degree at the Sandra Day O’Connor College of Law at Arizona State University in Tempe.

Return to Contents
 

 

G. Gregory Raab, Ph.D.

Health Policy Consultant

 

Dr. Raab is an independent health policy consultant with more than 30 years of experience in the government and business arenas and on Capitol Hill. His clients include medical technology associations and groups, as well as private companies that produce such products as drugs, biotechnology products, diagnostic imaging equipment, implantable medical devices, and clinical laboratory testing equipment and supplies. Dr. Raab has written and spoken widely on medical technology matters. He is a member of the National Committee for Quality Assurance Expert Laboratory Panel, which helps maintain the Healthcare Effectiveness Data and Information Set (HEDIS®). He also has served on the Medicare Coverage Advisory Committee of the Centers for Medicare & Medicaid Services (CMS).

Before beginning his consulting practice, Dr. Raab worked in both government and industry. Early in his career, he worked at the Health Care Financing Administration (now CMS) on a wide range of legislative and policy matters and at the U.S. Public Health Service, where he developed and implemented hospital capital-expenditure regulations. He then served as an aide to U.S. Senator Max Baucus (D-MT) in his role as the ranking Democratic member of the Senate Finance Committee’s Health Subcommittee, working on budget matters, hospital cost controls, physician peer review, and hospital prospective payment legislation. Dr. Raab left the government arena for the business arena. He first worked for Medtronic, Inc., handling corporate reimbursement matters, developing health policy and intellectual property positions for the company, and managing a series of legislative and regulatory initiatives involving both Medicare and the Food and Drug Administration (FDA). For this work, he received the Medtronic Leadership Award. Most recently, Dr. Raab held senior legislative and policy positions with the Advanced Medical Technology Association (AdvaMed). At AdvaMed, he represented medical technology interests on Capitol Hill on legislation involving Medicare, health reform, FDA regulations, and product liability. He also served as the Association’s representative at the CMS and at other Federal agencies and in study groups on health financing initiatives and coverage reform.

Dr. Raab earned his M.A. degree in government and his Ph.D. degree in public policy from the University of Virginia in Charlottesville.

Return to Contents
 

 

Alan B. Rosenberg, M.D.

Vice President of Medical Policy, Technology Assessment, and Credentialing Programs, WellPoint, Inc.
President, Anthem UM Services, Inc., and Anthem Credentialing Services, Inc.

 

Dr. Rosenberg is the vice president of the Medical Policy, Technology Assessment, and Credentialing Programs for WellPoint, Inc. Among his responsibilities, Dr. Rosenberg leads WellPoint's program — across all of its affiliated brands — for medical policy, technology assessment, credentialing, and training in clinical health policy. He also is president of Anthem UM Services, Inc., and of Anthem Credentialing Services, Inc. Before joining WellPoint, Dr. Rosenberg held the positions of Chief Medical Officer for Rush Prudential Health Plans, Director of Healthcare Business Consulting for Arthur Andersen, and Vice President of Medical Affairs and Medical Director for Aetna US Healthcare of the Midwest, Inc.

Dr. Rosenberg is a fellow of the Institute of Medicine of Chicago. He currently serves as a board member of the American Association of Preferred Provider Organizations and of the Utilization Review Accreditation Commission, a nonprofit organization that promotes continuous improvement in the quality and efficiency of health care management through processes of accreditation and education. Dr. Rosenberg is a member of the Medical Advisory and Medical Policy Panels for the Blue Cross Association’s Technology Evaluation Center and of various committees for America's Health Insurance Plans.

Dr. Rosenberg received his B.S. degree from Columbia University in New York and received his M.D. degree from New York University Medical School. He completed his residency at the University of Chicago Residency Program at Michael Reese Hospital and is board certified in internal medicine.

Return to Contents
 

 

Eric M. Wall, M.D., M.P.H.

Senior Medical Director, Qualis Health

 

Dr. Wall is the senior medical director of Qualis Health, a private, nonprofit health care Quality Improvement Organization based in Seattle, Washington. In this position, he is responsible for supervising the Medical Services Department and implementing the organization's key strategic goals. Dr. Wall also is a practicing family physician at the University of Washington's Belltown Clinic in Seattle, Washington.

Previously, Dr. Wall was the regional medical director for LifeWise Health Plan of Oregon and for Premera Blue Cross in Alaska. He also taught at the Oregon Health & Science University, holding academic appointments in the Departments of Family Medicine and of Public Health and Preventive Medicine and in the School of Nursing. Dr. Wall was the first director of research in the Department of Family Medicine. His research interests have focused on clinical decision-making, the development and implementation of clinical practice guidelines, and evidence-based maternity care.

Dr. Wall currently serves on the American Medical Association's Performance Measures and Evaluation Subcommittee. He previously chaired the American Academy of Family Physicians' Commission on Science. Dr. Wall has participated on numerous guideline-development panels. Most recently, he worked on the Low Back Pain Guideline Advisory Panel convened by the American Pain Society and the American College of Physicians.

Dr. Wall received his M.D. degree from the Catholic University of Louvain in Belgium and completed his family medicine residency at Jackson Memorial Hospital in Miami, Florida, which is affiliated with the University of Miami Miller School of Medicine. He received his M.P.H. degree from the University of Washington in Seattle.

Return to Contents
 

 

Anthony C. Wisniewski, Esq.

Senior Health Care Consultant for the U.S. Chamber of Commerce


Mr. Wisniewski is a senior health care consultant for the U.S. Chamber of Commerce. His primary responsibilities are to develop the Chamber’s policies on the health and life sciences and to advocate those policies before Congress and various Federal agencies.

Mr. Wisniewski began his law career in private practice at the firm of Tydings & Rosenberg L.L.P. in Baltimore, Maryland, where he focused on commercial business transactions and on government affairs at the local, State, and Federal levels. He left private practice to serve as the Senior Director of State Policy for the Pharmaceutical Research and Manufacturers of America, where he managed State policy operations for several regions across the United States. He then joined the biotechnology company MedImmune, Inc., where he served as head of public policy and policy counsel, overseeing the development and implementation of policy strategies for matters related to Federal, State, and international government affairs.

Currently, Mr. Wisniewski serves on the Board of Visitors of the University of Maryland Biotechnology Institute, the Quality Alliance Steering Committee, and the Hospital Quality Alliance. Mr. Wisniewski was appointed by President George W. Bush to the Board of Trustees of the Christopher Columbus Fellowship Foundation and by U.S. Secretary of Health and Human Services Michael O. Leavitt to the National Advisory Council of the Agency for Healthcare Research and Quality. He also is a former gubernatorial appointee to the Board of Directors of the Maryland Technology Development Corporation.

Mr. Wisniewski is admitted to the bars of both the State of Maryland and the District of Columbia. He received a B.A. degree in politics from The Catholic University of America in Washington, D.C., and a J.D. degree from the University of Notre Dame in Indiana.

Return to Contents